Literature DB >> 1580774

Risk factors for heterotopic ossification in children and adolescents with severe traumatic brain injury.

E A Hurvitz1, B R Mandac, G Davidoff, J H Johnson, V S Nelson.   

Abstract

Previous reports on the incidence of heterotopic ossification (HO) in children and adolescents with traumatic brain injury (TBI) have ranged from 3% to 20%. These studies mention HO briefly or address patient cohorts with coma more than three months. We reviewed the medical records of 90 children younger than 19 years old, who were comatose more than 24 hours after TBI. Mean followup was 33.1 months (range = 2 to 128 months). Incidence of HO was 14.4% (n = 13). One to five sites were involved, with hip and knee most frequent, followed by shoulder, elbow, and nonjoint sites. Children with HO were older than 11 years (relative risk [RR] = 18.85, confidence interval [CI] = 3.7, 95.7), had a greater length of coma (RR = 7.22, CI = 1.4, 37.1), and had a greater associated risk for poor functional outcome (RR = 2.89, CI = 1.02, 7.9) compared to those without RO. Multiple limb fractures showed a trend toward association with increased incidence of HO. Other factors, including gender, history of skull fracture, brain CAT scan findings, and presence of spasticity, were not predictive of HO. Eleven children were treated with etidronate, four with nonsteroidal antiinflammatory drugs, and one with surgery. Only three children had residual functional impairments attributed to the presence of HO.

Entities:  

Mesh:

Year:  1992        PMID: 1580774

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  10 in total

1.  Results and outcome predictors after open release of complete ankylosis of the elbow caused by heterotopic ossification.

Authors:  Shuai Chen; Jiazhi Liu; Jiangyu Cai; Wei Zheng; Zhiwei Li; Wei Chen; Cunyi Fan
Journal:  Int Orthop       Date:  2017-01-12       Impact factor: 3.075

2.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

3.  NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification.

Authors:  Emilie Barruet; Blanca M Morales; Corey J Cain; Amy N Ton; Kelly L Wentworth; Tea V Chan; Tania A Moody; Mariëlle C Haks; Tom Hm Ottenhoff; Judith Hellman; Mary C Nakamura; Edward C Hsiao
Journal:  JCI Insight       Date:  2018-11-15

Review 4.  Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification.

Authors:  Koji Matsuo; Robert Dalton Chavez; Emilie Barruet; Edward C Hsiao
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

Review 5.  [Research progress of traumatic heterotopic ossification].

Authors:  Guorui Cao; Fuxing Pei
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-03-15

Review 6.  The role of bisphosphonates in diseases of childhood.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Eur J Pediatr       Date:  2003-09-11       Impact factor: 3.183

Review 7.  Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva.

Authors:  Fatima Khan; Xiaobing Yu; Edward C Hsiao
Journal:  Biomedicines       Date:  2021-02-05

8.  Severe injury-induced osteoporosis and skeletal muscle mineralization: Are these related complications?

Authors:  Stephanie N Moore-Lotridge; Rivka Ihejirika; Breanne H Y Gibson; Samuel L Posey; Nicholas A Mignemi; Heather A Cole; Gregory D Hawley; Sasidhar Uppuganti; Jeffry S Nyman; Jonathan G Schoenecker
Journal:  Bone Rep       Date:  2020-12-26

Review 9.  Neurological heterotopic ossification: novel mechanisms, prognostic biomarkers and prophylactic therapies.

Authors:  Ker Rui Wong; Richelle Mychasiuk; Terence J O'Brien; Sandy R Shultz; Stuart J McDonald; Rhys D Brady
Journal:  Bone Res       Date:  2020-12-09       Impact factor: 13.567

10.  ACVR1R206H extends inflammatory responses in human induced pluripotent stem cell-derived macrophages.

Authors:  Koji Matsuo; Abigail Lepinski; Robert D Chavez; Emilie Barruet; Ashley Pereira; Tania A Moody; Amy N Ton; Aditi Sharma; Judith Hellman; Kiichiro Tomoda; Mary C Nakamura; Edward C Hsiao
Journal:  Bone       Date:  2021-07-24       Impact factor: 4.398

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.